Rosetta Launches Two New miRNA Tests As It Looks for Commercialization Partners | GenomeWeb
Rosetta Genomics this week announced the launch of its third microRNA diagnostic, achieving its long-stated goal of introducing three tests based on the small non-coding RNAs before the end of 2008.
 
A company official also last week disclosed pricing information and revenue guidance for the three products, and said that Rosetta is actively seeking marketing and distribution partners to speed their adoption in the US and overseas.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.